Click here to go to the previous page
Transforming Regulatory Information Into Actionable Regulatory Intelligence for Emerging Markets
Program Code:
110
Date:
Monday, June 25, 2012
Time:
10:00 AM to 11:30 AM
EST
CHAIR
:
Kim Quaintance, Eisai Inc., United States
PRESENTER
(S):
Linda is Sr. Director of Regulatory Policy & Intelligence at Sanofi and has held RA positions at Bayer and Block Drug/GSK, with global regulatory responsibilities for submissions, life cycle management and due diligence. She is a RAPS Fellow, RAC for US/CDN/EU, and is on the RAPS Board.
|
Agustina Bisio, Administración Nacional De Medicamentos, Alimentos Y Tecnología Médica (ANMAT), Argentina
Laura Castanheira, National Health Surveillance Agency (ANVISA), Brazil
Brooke has more than 10 years Regulatory experience as a strategist and publishing expert in global markets. She is the Chairperson of the DIA Regulatory Intelligence SIAC and active member in various organizations to promote Regulatory awareness.
|
Description
Industry representatives and an emerging market health authority will discuss gathering and management of regulatory intelligence from rapidly evolving emerging markets.
Learning Objectives:
Identify various sources for regulatory information
Describe real-life experiences working with emerging markets
Discuss methods for implementing and disseminating regulatory intelligence within our organization.